PD-1 Antibody and Sapropterin Dihydrochloride in Patients With PDAC

Clinical trial NCT06396637 · UNKNOWN

Trial details

NCT number: NCT06396637
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma Metastatic

Start date: 2024-04-30
Primary completion: 2025-04-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.